Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 54, Issue 11, Pages 2042-2050
Publisher
Oxford University Press (OUP)
Online
2015-07-08
DOI
10.1093/rheumatology/kev226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A non-complement-fixing antibody to 2 glycoprotein I as a novel therapy for antiphospholipid syndrome
- (2014) C. Agostinis et al. BLOOD
- Value of Isolated IgA Anti-β2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome
- (2013) Vijaya Murthy et al. ARTHRITIS AND RHEUMATISM
- Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review
- (2013) D. Garcia et al. BLOOD
- Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies
- (2013) Laura Andreoli et al. Current Rheumatology Reports
- Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome
- (2011) Beverley J. Hunt et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010
- (2011) ML Bertolaccini et al. LUPUS
- Evaluating the conformation of recombinant domain I of β2-glycoprotein I and its interaction with human monoclonal antibodies
- (2011) Charis Pericleous et al. MOLECULAR IMMUNOLOGY
- Anti- 2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?
- (2010) L. Andreoli et al. ANNALS OF THE RHEUMATIC DISEASES
- Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome
- (2010) E. Ortona et al. BLOOD
- Antiphospholipid antibody profile: implications for the evaluation and management of patients
- (2010) A. Tincani et al. LUPUS
- The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
- (2010) JH Rand et al. LUPUS
- Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
- (2009) J. H. Rand et al. BLOOD
- Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions
- (2009) I. Giles et al. JOURNAL OF IMMUNOLOGY
- In vivoinhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
- (2009) Y. IOANNOU et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
- (2009) B. DE LAAT et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started